✦ LIBER ✦

Pap-1, a Small Molecule Kv1.3 Blocker, for the Treatment of Effector Memory T-Cell Mediated Autoimmune Diseases

✍ Scribed by Philippe Azam; Ananthakrishnan Sankaranarayanan; Daniel Homerick; Heike Wulff

Book ID: 116366635
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 48 KB
Volume: 119
Category: Article
ISSN: 1090-2341
DOI: 10.1016/j.clim.2006.04.415

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Targeting Effector Memory T Cells with t

Targeting Effector Memory T Cells with the Small Molecule Kv1.3 Blocker PAP-1 Suppresses Allergic Contact Dermatitis

✍ Azam, Philippe; Sankaranarayanan, Ananthakrishnan; Homerick, Daniel; Griffey, St 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 321 KB

T.82. Blocking the Effects of MCP-1 Usin

T.82. Blocking the Effects of MCP-1 Using a New Small Molecule Antagonist SR16951 for the Treatment of Autoimmune Diseases

✍ Jennifer Lam; Carsten Alt; Claude Bernard; Edgardo Laborde; Annalisa D'Andrea 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 38 KB

Durable Pharmacological Responses from t

Durable Pharmacological Responses from the Peptide ShK-186, a Specific Kv1.3 Channel Inhibitor That Suppresses T Cell Mediators of Autoimmune Disease

✍ Tarcha, E. J.; Chi, V.; Munoz-Elias, E. J.; Bailey, D.; Londono, L. M.; Upadhyay 📂 Article 📅 2012 🏛 American Society for Pharmacology and Experimental 🌐 English ⚖ 862 KB